IDXX Insider Trading

Insider Ownership Percentage: 0.98%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $6,269,435.94

IDEXX Laboratories Insider Trading History Chart

This chart shows the insider buying and selling history at IDEXX Laboratories by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$20M-$10M$0$10M$20MTotal Insider BuyingTotal Insider Selling

IDEXX Laboratories Share Price & Price History

Current Price: $436.97
Price Change: Price Increase of +2.98 (0.69%)
As of 04/29/2025 05:00 PM ET

This chart shows the closing price history over time for IDXX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
JunJulAugSepOctNovDecJanFebMarApr$436.97Closing price on 04/29/25:

SEC Filings (Institutional Ownership Changes) for IDEXX Laboratories (NASDAQ:IDXX)

87.84% of IDEXX Laboratories stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at IDXX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$815Mbought$140MsoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$50B$0$50BTotal InflowsTotal Outflows
IDEXX Laboratories logo
IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
Read More on IDEXX Laboratories

Today's Range

Now: $436.97
Low: $429.11
High: $439.01

50 Day Range

MA: $419.27
Low: $361.04
High: $463.66

52 Week Range

Now: $436.97
Low: $356.14
High: $548.88

Volume

718,305 shs

Average Volume

635,381 shs

Market Capitalization

$35.41 billion

P/E Ratio

40.95

Dividend Yield

N/A

Beta

1.5

Who are the company insiders with the largest holdings of IDEXX Laboratories?

IDEXX Laboratories' top insider investors include:
  1. Jonathan W Ayers (Director)
  2. Jonathan Jay Mazelsky (CEO)
  3. Brian P Mckeon (CFO)
  4. James F Polewaczyk (EVP)
  5. George Fennell (EVP)
  6. George Fennell (SVP)
  7. Michael Lane (EVP)
  8. M Anne Szostak (Director)
  9. Sophie V Vandebroek (Director)
  10. Bruce L Claflin (Director)
Learn More about top insider investors at IDEXX Laboratories.

Who are the major institutional investors of IDEXX Laboratories?

IDEXX Laboratories' top institutional shareholders include:
  1. Principal Financial Group Inc. — 1.39%
  2. GAMMA Investing LLC — 1.13%
  3. Bank of New York Mellon Corp — 0.70%
  4. Vontobel Holding Ltd. — 0.56%
  5. Bessemer Group Inc. — 0.42%
  6. Seilern Investment Management Ltd — 0.33%
Learn More about top institutional investors of IDEXX Laboratories stock.

Which institutional investors are selling IDEXX Laboratories stock?

During the previous quarter, IDXX stock was sold by these institutional investors:
  1. Assenagon Asset Management S.A.
  2. Robeco Institutional Asset Management B.V.
  3. KBC Group NV
  4. Bank of New York Mellon Corp
  5. Bourne Lent Asset Management Inc.
  6. Seilern Investment Management Ltd
  7. New York State Teachers Retirement System
  8. Mn Services Vermogensbeheer B.V.
During the previous year, company insiders that have sold IDEXX Laboratories company stock include:
  1. Jonathan W Ayers (Director)
  2. Jonathan Jay Mazelsky (CEO)
  3. Brian P Mckeon (CFO)
  4. James F Polewaczyk (EVP)
Learn More investors selling IDEXX Laboratories stock.

Which institutional investors are buying IDEXX Laboratories stock?

In the last quarter, IDXX stock was purchased by institutional investors including:
  1. GAMMA Investing LLC
  2. Principal Financial Group Inc.
  3. Bessemer Group Inc.
  4. SG Americas Securities LLC
  5. Vantage Investment Partners LLC
  6. Vontobel Holding Ltd.
  7. Teacher Retirement System of Texas
  8. Franklin Street Advisors Inc. NC